Science1 publisher2 min readPublished
Lymph-node-like immune hubs in mouse skull bone marrow respond to glioblastoma before distant nodes do
The WashU group reports in Nature that the structures activate in mice before distant lymph nodes get the signal, and that a gel of three immune proteins placed under the scalp boosted the antitumor response.
The Scientist · Science desk
What happened
- Those hubs became active against brain cancer before more distant lymph nodes received signals that anything was wrong, according to the WashU team.
- Going the other way, the team combined three immune-boosting proteins in a gel and placed it directly beneath the scalp, which set off a surge of immune activity against the tumors.
- The researchers also report evidence of similar immune cells in human skull bone marrow. They take that as evidence the local defense system is not confined to mice.
Compiled by The ScientistSomething wrong?How this is made
Why it matters
- capability Because the structures sit in skull bone and the gel acted from under the scalp, a candidate target for brain-tumor immunotherapy is reachable without going into the brain at all.
- constraint In people, that injection site has no confirmed target yet. Someone has to show the organized hubs in human skull marrow before a scalp-delivered therapy has something to aim at.
- decision Where the drug goes becomes a variable a glioblastoma immunotherapy experiment has to choose and test, and the skull is now one of the options on that list.
Two earlier findings from Jonathan Kipnis's lab set this up. The group reported lymphatic vessels in the dura mater, the tissue layer just beneath the skull [7]. Later it found small channels bridging skull, dura and brain tissue, and immune cells and cellular waste can move along them [8]. In the new work the team followed proteins out of the brain along that route and into the skull marrow. There they found immune structures organized the way the inside of a lymph node is organized [1]. The paper is in Nature, and the authors describe it as the first to identify immune hubs of this kind inside bone [13].
"This study reveals that the skull bone marrow is far more than just a structural framework -- it harbors previously unrecognized hubs for brain-specific immune responses," said Kipnis, the study's senior author [12].
That arrangement belongs to lymph nodes, where T follicular helper cells support B cells that then make antibodies in quantity [9]. Healthy bone marrow was not thought to contain it [10]. "We have never seen such structures in healthy bone marrow before," said Jang Hyun Park, the study's first author [11].
The tumor experiments went in both directions. In a mouse glioblastoma model, a drug that interfered with the skull hubs left tumors growing faster and the animals surviving for less time than mice whose hubs stayed intact [3]. Then the team went the other way, combining three immune-boosting proteins in a gel and placing it directly beneath the scalp. That set off a surge of immune activity against the tumors [4]. WashU's summary of the work says strengthening the local defense improved tumor rejection and survival [6]. Knocking a structure's function down and then pushing it up tests the same structure twice, which is stronger evidence than showing it sits near the tumor [15].
The WashU account does not report group sizes or survival times [17].
The gel went under the scalp, outside the brain [4]. In a person, that injection site would be aiming at whatever human skull marrow actually contains. What the team reports finding there is evidence of similar immune cells [5], not the organized hubs the mouse experiments switched off and boosted [16].
What to watch
- Whether the Nature paper's human data show organized hub structures in skull marrow or only the immune cell types.
- The survival numbers behind both arms: hub-disrupted versus intact mice, and gel-treated versus untreated.
- Whether the scalp gel is repeated in a second brain tumor model, or by a group outside the Kipnis lab.